Drugs / MVC-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04891718 | Sep 2021 → Jun 2022 | cancer | Presage Biosciences | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVC-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04891718 ↗ |
| Route | Other | “Intratumoural microdose injection by the CIVO device.” NCT04891718 ↗ |